Gyre Therapeutics, Inc. (GYRE)
6.775
+0.08
(+1.27%)
USD |
NASDAQ |
Sep 16, 11:05
Gyre Therapeutics Price : 6.775 for Sept. 16, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | 6.69 | 6.716 | 6.46 | 6.69 | 97767.00 |
| Sep 14, 2026 | 6.82 | 7.035 | 6.685 | 6.69 | 104123.0 |
| Sep 11, 2026 | 6.86 | 6.95 | 6.73 | 6.73 | 69803.00 |
| Sep 10, 2026 | 6.93 | 6.96 | 6.74 | 6.74 | 83103.00 |
| Sep 09, 2026 | 7.17 | 7.265 | 6.94 | 6.95 | 104720.0 |
| Sep 08, 2026 | 6.85 | 7.20 | 6.85 | 7.17 | 240884.0 |
| Sep 04, 2026 | 6.44 | 6.89 | 6.41 | 6.86 | 56024.00 |
| Sep 03, 2026 | 6.37 | 6.54 | 6.36 | 6.44 | 41205.00 |
| Sep 02, 2026 | 6.41 | 6.67 | 6.337 | 6.36 | 58067.00 |
| Sep 01, 2026 | 6.51 | 6.57 | 6.32 | 6.47 | 54547.00 |
| Aug 31, 2026 | 6.60 | 6.64 | 6.43 | 6.57 | 41714.00 |
| Aug 28, 2026 | 6.70 | 6.70 | 6.54 | 6.59 | 43162.00 |
| Aug 27, 2026 | 6.63 | 6.77 | 6.63 | 6.68 | 25344.00 |
| Aug 26, 2026 | 6.71 | 6.81 | 6.60 | 6.65 | 38820.00 |
| Aug 25, 2026 | 6.53 | 6.72 | 6.49 | 6.68 | 44550.00 |
| Aug 24, 2026 | 6.89 | 6.89 | 6.42 | 6.44 | 53276.00 |
| Aug 21, 2026 | 7.08 | 7.12 | 6.86 | 6.91 | 65999.00 |
| Aug 20, 2026 | 7.15 | 7.29 | 6.77 | 7.02 | 55088.00 |
| Aug 19, 2026 | 7.06 | 7.27 | 7.03 | 7.15 | 87802.00 |
| Aug 18, 2026 | 6.73 | 7.00 | 6.72 | 6.98 | 49593.00 |
| Aug 17, 2026 | 6.62 | 6.83 | 6.55 | 6.81 | 47650.00 |
| Aug 14, 2026 | 6.55 | 6.73 | 6.47 | 6.68 | 52735.00 |
| Aug 13, 2026 | 6.70 | 6.77 | 6.44 | 6.54 | 48968.00 |
| Aug 12, 2026 | 6.68 | 6.99 | 6.62 | 6.66 | 94545.00 |
| Aug 11, 2026 | 6.76 | 6.925 | 6.58 | 6.64 | 50219.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Cytokinetics, Inc. | 69.85 |
| ACADIA Pharmaceuticals, Inc. | 27.17 |
| Alnylam Pharmaceuticals, Inc. | 237.87 |
| Anika Therapeutics, Inc. | 21.08 |
| Savara, Inc. | 5.285 |
Price Related Metrics
| PS Ratio | 5.492 |
| PEG Ratio | -0.0212 |
| Price to Book Value | 6.656 |
| Earnings Yield | -2.89% |
| Market Cap | 718.38M |
| PEGY Ratio | -0.0212 |